Literature DB >> 11010222

Direct and indirect costs of schizophrenia in community psychiatric services in Italy. The GISIES study. Interdisciplinary Study Group on the Economic Impact of Schizophrenia.

R Tarricone1, S Gerzeli, R Montanelli, L Frattura, M Percudani, G Racagni.   

Abstract

BACKGROUND: The present work is a cost-of-illness (COI) study that aims at assessing total direct and indirect costs of schizophrenic patients in community psychiatric services in Italy and identifying the variables that influence costs.
METHODS: A retrospective prevalence-based multi-centre COI study, was designed. Ten community mental health centres (CMHC) were involved and 100 patients were recruited. Data on patients' costs were gathered through specifically designed instruments.
RESULTS: More than half total direct costs were attributed to CMHC interventions. The yearly average costs of schizophrenia per patient amounted to nearly ITL 50 million: 30% for direct costs and 70% for indirect costs.
CONCLUSION: CMHCs tend to manage long-term ill patients by adopting a strong community-based system of care. Schizophrenia is correlated to loss of working days and lack of well-being. From the results of this study, it might be argued that the de-institutionalisation programme has produced 'spillovers' in terms of families' greater involvement in patients management.

Entities:  

Mesh:

Year:  2000        PMID: 11010222     DOI: 10.1016/s0168-8510(99)00078-0

Source DB:  PubMed          Journal:  Health Policy        ISSN: 0168-8510            Impact factor:   2.980


  14 in total

Review 1.  Cost-of-illness studies : a review of current methods.

Authors:  Ebere Akobundu; Jing Ju; Lisa Blatt; C Daniel Mullins
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

2.  Cost of major mental disorders in Delhi, India.

Authors:  S Thakral; N N Mishra; T Bhatia; S N Deshpande
Journal:  Asian J Psychiatr       Date:  2011-05-13

Review 3.  The Cost of Relapse in Schizophrenia.

Authors:  Mark Pennington; Paul McCrone
Journal:  Pharmacoeconomics       Date:  2017-09       Impact factor: 4.981

Review 4.  Head-to-head comparison of the costs of atypical antipsychotics: a systematic review.

Authors:  Corrado Barbui; Camilla Lintas; Mauro Percudani
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

5.  Direct costs of schizophrenia in Italian community psychiatric services.

Authors:  L Garattini; C Rossi; F Tediosi; C Cornaggia; G Covelli; C Barbui; F Parazzini
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 6.  Effect of second-generation antipsychotics on employment and productivity in individuals with schizophrenia: an economic perspective.

Authors:  Mauro Percudani; Corrado Barbui; Michele Tansella
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

7.  Overview and emerging trends.

Authors:  Sandeep Grover; Ajit Avasthi; Subho Chakrabarti; Paramanand Kulhara
Journal:  Indian J Psychiatry       Date:  2005-10       Impact factor: 1.759

Review 8.  The burden of schizophrenia on caregivers: a review.

Authors:  A George Awad; Lakshmi N P Voruganti
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

9.  Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: a cost effectiveness study.

Authors:  Maria Geitona; Hara Kousoulakou; Markos Ollandezos; Kostas Athanasakis; Sotiria Papanicolaou; Ioannis Kyriopoulos
Journal:  Ann Gen Psychiatry       Date:  2008-08-28       Impact factor: 3.455

10.  An investigation of economic costs of schizophrenia in two areas of China.

Authors:  Jinguo Zhai; Xiaofeng Guo; Min Chen; Jingping Zhao; Zhonghua Su
Journal:  Int J Ment Health Syst       Date:  2013-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.